Immunome Submits Desmoid Tumor Treatment to FDA Following Successful Phase III Trial Results

Immunome Submits Desmoid Tumor Treatment to FDA Following Successful Phase III Trial Results

Immunome Submits Desmoid Tumor Treatment to FDA Following Successful Phase III Trial Results